Despite an increasing number of available therapies, the treatment of neuropathic pain
remains a major issue. Systematic reviews and meta‐analyses indicate that only a minority …

Patients with neuropathic pain (NP) are challenging to manage and evidence-based clinical
recommendations for pharmacologic management are needed. Systematic literature …

BACKGROUND: Neuropathic pain (NeP), redefined as pain caused by a lesion or a disease
of the somatosensory system, is a disabling condition that affects approximately two million …

Neuropathic pain remains a significant unmet medical need. Several recommendations
have recently been proposed concerning pharmacotherapy, neurostimulation techniques …

Neuropathic pain is a challenging chronic pain condition. Limited knowledge exists
regarding the relative effectiveness of pharmacological treatments, and differences in trial …

Background New drug treatments, clinical trials, and standards of quality for assessment of
evidence justify an update of evidence-based recommendations for the pharmacological …

Neuropathic pain (NP) is a significant medical and socioeconomic burden. Epidemiological
surveys have indicated that many patients with NP do not receive appropriate treatment for …

Randomized, double-blind, placebo-controlled trials on neuropathic pain treatment are
accumulating, so an updated review of the available evidence is needed. Studies were …

Introduction Epidemiological studies have shown that 6.9–10% of people suffer from
neuropathic pain, a complex painful condition which is often undertreated. Data regarding …

Neuropathic pain, comprising a range of heterogeneous conditions, is often severe and
difficult to manage, and this may result in a chronic condition that negatively affects the …